VNA or PACS-centric Models Lead Enterprise Imaging Plans

Article

Most healthcare providers developing an enterprise imaging strategy are considering a vendor-neutral archive or a PACS enterprise archive solution, KLAS found.

Most healthcare providers developing an enterprise imaging strategy are considering a vendor-neutral archive or a PACS enterprise archive solution, according to a new KLAS report.

The report, Enterprise Imaging 2012: Provider’s Strategies and Insights, found that most providers are in the early stages of forming the strategy that would allow access to images at the right time and place, according to market research firm KLAS.

"Image storage is a necessity, no matter what option is chosen," said Ben Brown, imaging research director and author of the report. "As providers start to bring in more studies and the studies themselves increase in size, the need for storage will increase. In addition, as a provider explained, images will need to be managed as well as stored."

Of the providers interviewed, 27 percent said that a vendor-neutral archive (VNA) would be central to their strategy. This option was selected most often by hospitals with more than 500 beds. A PACS-centric archive solution was selected by 25 percent of providers, most of them facilities with fewer than 500 beds.

GE and Philips were mentioned most often by those interviewed, and customers said they considered their vendor to be part of the imaging strategy moving forward, particularly for a PACS-centric approach. Fuji also has a strong PACS enterprise archive offering, according to KLAS. Agfa and Merge were most often cited for VNA approaches.

Provider Reported Enterprise Imaging Strategy:


 chart credit: KLAS

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.